Literature DB >> 29278704

HDAC6 interacts with PTPN1 to enhance melanoma cells progression.

Jiaqi Liu1, Wenjie Luan2, Yong Zhang3, Jianying Gu4, Yuedong Shi5, Yanwen Yang6, Zihao Feng7, Fazhi Qi8.   

Abstract

Histone deacetylase 6 (HDAC6) plays an important role in oncogenic transformation and cancer metastasis. Our previous study has demonstrated that HDAC6 was highly expressed in melanoma cells, and contributed to the proliferation and metastasis of melanoma cells. However, the underlying mechanism of HDAC6 in melanoma metastasis and progression remains largely unclear. In this study, we reported that HDAC6 directly interacted with Tyrosine-protein phosphatase non-receptor type 1 (PTPN1) by performing co-immunoprecipitation (Co-IP) combined with liquid chromatography tandem mass spectrometry (LC-MS/MS). HDAC6 increased the protein level of PTPN1 independent of histone modifying activity. In addition, PTPN1 promoted proliferation, colony formation and migration while decreased apoptosis of melanoma cells through activating extracellular signal-regulated kinase 1/2 (ERK1/2). Furthermore, we found that matrix metallopeptidase 9 (MMP9) was increased by HDAC6/PTPN1/ERK1/2 axis, which might serve as a mechanism for melanoma invasion and metastasis. In conclusion, HDAC6 might enhance aggressive melanoma cells progression via interacting with PTPN1, which was independent of its histone modifying activity.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  ERK1/2; HDAC6; MMP9; Melanoma; PTPN1

Mesh:

Substances:

Year:  2017        PMID: 29278704     DOI: 10.1016/j.bbrc.2017.12.145

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  miRNA-451 regulates rhesus choroid-retinal endothelial cell function and proteome profile.

Authors:  Hong-Lian Wu; Yan Shao; Zhen-Na Chen; Hui Zhang; Xiao-Min Zhang; Xiao-Rong Li
Journal:  Int J Ophthalmol       Date:  2022-06-18       Impact factor: 1.645

Review 2.  HDAC6: A unique HDAC family member as a cancer target.

Authors:  Sumeet Kaur; Prerna Rajoria; Madhu Chopra
Journal:  Cell Oncol (Dordr)       Date:  2022-08-29       Impact factor: 7.051

3.  Histone deacetylase inhibitors (HDACi) increase expression of KCa2.3 (SK3) in primary microvascular endothelial cells.

Authors:  Aaron Kolski-Andreaco; Corina M Balut; Claudia A Bertuccio; Annette S Wilson; William M Rivers; Xiaoning Liu; Robin E Gandley; Adam C Straub; Michael B Butterworth; David Binion; Daniel C Devor
Journal:  Am J Physiol Cell Physiol       Date:  2022-01-19       Impact factor: 4.249

4.  Pristimerin inhibits glioma progression by targeting AGO2 and PTPN1 expression via miR-542-5p.

Authors:  Zaiyu Li; Cong Hu; Yu Zhen; Bo Pang; Huanfa Yi; Xianglin Chen
Journal:  Biosci Rep       Date:  2019-05-14       Impact factor: 3.840

5.  Upregulated Histone Deacetylase 6 Associates with Malignant Progression of Melanoma and Predicts the Prognosis of Patients.

Authors:  Zhicheng Hu; Yanchao Rong; Shuting Li; Shanqiang Qu; Shaobin Huang
Journal:  Cancer Manag Res       Date:  2020-12-17       Impact factor: 3.989

6.  Whole-exome sequencing identifies prognostic mutational signatures in gastric cancer.

Authors:  Zhenxin Zhu; Hongbing Fu; Shengzhou Wang; Xinxin Yu; Qing You; Mengyao Shi; Chun Dai; Guan Wang; Wei Cha; Weimin Wang
Journal:  Ann Transl Med       Date:  2020-11

Review 7.  Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant.

Authors:  Elaine C D Gonçalves; Gabriela M Baldasso; Maíra A Bicca; Rodrigo S Paes; Raffaele Capasso; Rafael C Dutra
Journal:  Molecules       Date:  2020-03-29       Impact factor: 4.411

8.  Indocyanine Green-Nexturastat A-PLGA Nanoparticles Combine Photothermal and Epigenetic Therapy for Melanoma.

Authors:  Debbie K Ledezma; Preethi B Balakrishnan; Juliana Cano-Mejia; Elizabeth E Sweeney; Melissa Hadley; Catherine M Bollard; Alejandro Villagra; Rohan Fernandes
Journal:  Nanomaterials (Basel)       Date:  2020-01-17       Impact factor: 5.076

9.  Structure-based prediction of HDAC6 substrates validated by enzymatic assay reveals determinants of promiscuity and detects new potential substrates.

Authors:  Julia K Varga; Kelsey Diffley; Katherine R Welker Leng; Carol A Fierke; Ora Schueler-Furman
Journal:  Sci Rep       Date:  2022-02-02       Impact factor: 4.379

10.  Knockdown of DEAD-box RNA helicase 52 (DDX52) suppresses the proliferation of melanoma cells in vitro and of nude mouse xenografts by targeting c-Myc.

Authors:  Qiang Wang; Leqi Qian; Mengyuan Tao; Jiaqi Liu; Fa-Zhi Qi
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.